Evidence map›Paper›PMID 42500709›Full record

ReviewSmart molecules : open access2026

Stimuli-responsive nanostructured hydrogen sulfide donors for enhanced cancer treatments.

Yuxuan Lyu, Jiaxuan Zhu, Lei Lei, Qingyang Zhong, Zhao Li, Caihong Lei, Fan Rong, Yin Wang

Abstract readReview
In one paragraph

Review in Smart molecules : open access, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yuxuan LyuSchool of Pharmacy Shihezi University Shihezi China.
Jiaxuan ZhuInternational Joint Laboratory of Green Textile (Zhejiang Sci-Tech University) Ministry of Education Engineering Research Center of Cell & Therapeutic Antibody Shanghai Frontiers Science Center of Drug Target Identification and Delivery National Key Laboratory of Innovative Immunotherapy School of Pharmaceutical Sciences Shanghai Jiao Tong University Shanghai China.
Lei LeiInternational Joint Laboratory of Green Textile (Zhejiang Sci-Tech University) Ministry of Education Engineering Research Center of Cell & Therapeutic Antibody Shanghai Frontiers Science Center of Drug Target Identification and Delivery National Key Laboratory of Innovative Immunotherapy School of Pharmaceutical Sciences Shanghai Jiao Tong University Shanghai China.
Qingyang ZhongDepartment of Gastroenterology and Hepatology Zhongshan Hospital Fudan University Shanghai China.
Zhao LiInnoPep, Inc. San Diego California USA.
Caihong LeiInternational Joint Laboratory of Green Textile (Zhejiang Sci-Tech University) Ministry of Education Zhejiang Provincial Key Laboratory of Fiber Materials and Manufacturing Technology Zhejiang Sci-Tech University Hangzhou China.
Fan RongInternational Joint Laboratory of Green Textile (Zhejiang Sci-Tech University) Ministry of Education Engineering Research Center of Cell & Therapeutic Antibody Shanghai Frontiers Science Center of Drug Target Identification and Delivery National Key Laboratory of Innovative Immunotherapy School of Pharmaceutical Sciences Shanghai Jiao Tong University Shanghai China.
Yin WangInternational Joint Laboratory of Green Textile (Zhejiang Sci-Tech University) Ministry of Education Engineering Research Center of Cell & Therapeutic Antibody Shanghai Frontiers Science Center of Drug Target Identification and Delivery National Key Laboratory of Innovative Immunotherapy School of Pharmaceutical Sciences Shanghai Jiao Tong University Shanghai China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer has become one of the leading causes to human death, which promotes scientists to develop various treatment modalities. Among them, hydrogen sulfide (H

Indexed as

cancer treatmentcontrolled drug deliveryhydrogen sulfidenanostructures

Identifiers

PMID42500709
PMCPMC13399186

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.